Endotoxin-neutralizing properties of the 25 kD N-terminal fragment and a newly isolated 30 kD C-terminal fragment of the 55-60 kD bactericidal/permeability-increasing protein of human neutrophils

The bactericidal/permeability-increasing protein (BPI) of polymorphonuclear leukocytes (PMN) is a potent cytotoxin, specific for Gram-negative bacteria, that also inhibits endotoxin activity by neutralizing isolated bacterial lipopolysaccharides (LPS). We have previously shown that an isolated 25 kD N-terminal fragment of human BPI carries all the antibacterial activities of the parent 55-60 kD molecule. In this study we have compared the LPS-neutralizing activities of human holo-BPI, the N-terminal fragment and a 30 kD C- terminal fragment that we have now isolated. We show that the N- terminal fragment also has LPS-neutralizing activity as detected by inhibition (up to 95%) of (a) activation by LPS of procoagulant proteases in Limulus amebocyte lysates, (b) LPS "priming" of PMN, and (c) LPS-mediated production of tumor necrosis factor in whole human blood. Holo-BPI and the 25 kD fragment have similar neutralizing potency (in nanomolar range) in all assays toward "smooth" LPS from Escherichia coli O111:B4 and O55:B5 (possessing long chain polysaccharide or O-antigen), and "deep rough" LPS from Salmonella minnesota Re595 mutant (possessing no O-antigen). The C-terminal fragment of BPI is devoid of antibacterial activity when tested against BPI-sensitive E. coli J5, but does have endotoxin-neutralizing activity. This activity is weak relative to holo-BPI and the 25 kD N- terminal fragment in the Limulus and PMN-priming assay, but is comparable for inhibition of TNF production in whole blood. We conclude that the principal determinants for LPS recognition and neutralization, like those for antibacterial action, reside in the N-terminal half of the BPI molecule, but that sites within the C-terminal half can also contribute to BPI-LPS interaction once LPS is detached from the bacterial envelope.

[1]  I. Čižnár,et al.  Lipopolysaccharides of Gram-Negative Bacteria , 2019, Handbook of Biochemistry and Molecular Biology.

[2]  R. Ulevitch,et al.  Structure and function of lipopolysaccharide binding protein. , 1990, Science.

[3]  P. Elsbach,et al.  Separation of sublethal and lethal effects of the bactericidal/permeability increasing protein on Escherichia coli. , 1990, The Journal of clinical investigation.

[4]  L. Sklar,et al.  Priming of Polymorphonuclear Granulocytes by Lipopolysaccharides and Its Complexes With Lipopolysaccharide Binding Protein and High Density Lipoprotein , 1990, Journal of leukocyte biology.

[5]  C. Raetz,et al.  Biosynthesis and function of phospholipids in Escherichia coli. , 1990, The Journal of biological chemistry.

[6]  M. N. Marra,et al.  Bactericidal/permeability-increasing protein has endotoxin-neutralizing activity. , 1990, Journal of Immunology.

[7]  R. Ulevitch,et al.  Lipopolysaccharide (LPS) binding protein opsonizes LPS-bearing particles for recognition by a novel receptor on macrophages , 1989, The Journal of experimental medicine.

[8]  R. Ulevitch,et al.  Identification of a lipid A binding site in the acute phase reactant lipopolysaccharide binding protein. , 1989, The Journal of biological chemistry.

[9]  C. E. Ooi,et al.  Cloning of the cDNA of a human neutrophil bactericidal protein. Structural and functional correlations. , 1989, The Journal of biological chemistry.

[10]  P. Elsbach,et al.  Preferential binding of the neutrophil cytoplasmic granule-derived bactericidal/permeability increasing protein to target bacteria. Implications and use as a means of purification. , 1989, Journal of immunology.

[11]  D. Morrison,et al.  Endotoxic-lipopolysaccharide-specific binding proteins on lymphoid cells of various animal species: association with endotoxin susceptibility , 1989, Infection and immunity.

[12]  J. Shelhamer,et al.  Bacterial lipopolysaccharides prime human neutrophils for enhanced production of leukotriene B4. , 1989, The Journal of clinical investigation.

[13]  R. Ulevitch,et al.  A family of lipopolysaccharide binding proteins involved in responses to gram-negative sepsis. , 1988, The Journal of biological chemistry.

[14]  C. E. Ooi,et al.  A 25-kDa NH2-terminal fragment carries all the antibacterial activities of the human neutrophil 60-kDa bactericidal/permeability-increasing protein. , 1987, The Journal of biological chemistry.

[15]  I. Olsson,et al.  Cellular and subcellular localization of the bactericidal/permeability-increasing protein of neutrophils. , 1987, Blood.

[16]  R. Munford,et al.  Detoxification of bacterial lipopolysaccharides (endotoxins) by a human neutrophil enzyme. , 1986, Science.

[17]  R. Ulevitch,et al.  Isolation of a lipopolysaccharide-binding acute phase reactant from rabbit serum , 1986, The Journal of experimental medicine.

[18]  P. Elsbach,et al.  The role of lipopolysaccharides in the action of the bactericidal/permeability-increasing neutrophil protein on the bacterial envelope. , 1984, Journal of immunology.

[19]  J. Shelhamer,et al.  Human pulmonary macrophage-derived mucus secretagogue , 1984, The Journal of experimental medicine.

[20]  P. Elsbach,et al.  Role of charge and hydrophobic interactions in the action of the bactericidal/permeability-increasing protein of neutrophils on gram-negative bacteria. , 1983, The Journal of clinical investigation.

[21]  J. Lipton,et al.  Biological activity, lipoprotein-binding behavior, and in vivo disposition of extracted and native forms of Salmonella typhimurium lipopolysaccharides. , 1982, The Journal of clinical investigation.

[22]  R. Munford,et al.  Sites of tissue binding and uptake in vivo of bacterial lipopolysaccharide-high density lipoprotein complexes: studies in the rat and squirrel monkey. , 1981, The Journal of clinical investigation.

[23]  R. Ulevitch,et al.  New function for high density lipoproteins. Isolation and characterization of a bacterial lipopolysaccharide-high density lipoprotein complex formed in rabbit plasma. , 1981, The Journal of clinical investigation.

[24]  P. Elsbach,et al.  Resistance of gram-negative bacteria to purified bactericidal leukocyte proteins: relation to binding and bacterial lipopolysaccharide structure. , 1980, The Journal of clinical investigation.

[25]  H. Towbin,et al.  Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. , 1979, Proceedings of the National Academy of Sciences of the United States of America.

[26]  H. Odeberg,et al.  Purification and characterization of a potent bactericidal and membrane active protein from the granules of human polymorphonuclear leukocytes. , 1978, The Journal of biological chemistry.

[27]  L. Jl Gram-negative sepsis. , 1976, Delaware medical journal.

[28]  J. Carrizosa Gram-negative sepsis. , 1976, Journal of the American Medical Women's Association.

[29]  U. K. Laemmli,et al.  Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4 , 1970, Nature.

[30]  J. Hannigan,et al.  Randomized Placebo-controlled Study of E5 Monoclonal Antiendotoxin Antibody , 1990 .

[31]  J. Harlan,et al.  Production of human tumor necrosis factor from whole blood ex vivo. , 1989, Lymphokine research.

[32]  S. Shak Leukotriene B4 catabolism: quantitation of leukotriene B4 and its omega-oxidation products by reversed-phase high-performance liquid chromatography. , 1987, Methods in enzymology.

[33]  D. C. Morrison,et al.  Endotoxins and disease mechanisms. , 1987, Annual review of medicine.

[34]  E. Rietschel,et al.  Lipopolysaccharides of Gram-Negative Bacteria , 1982 .

[35]  Friedrich Miescher-Institut Electrophoretic transfer ofproteins frompolyacrylamide gelsto nitrocellulose sheets: Procedure andsomeapplications , 1979 .